Because individuals with DS have chronic, hyperactive IFN signaling (Sullivan et al., 2016), we hypothesized that Mediator kinase inhibition would antagonize inflammatory signaling cascades in T21 cells. This evidence concerns the gene IFNA1 and Dravet syndrome.